8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Oct 9, 2012)

Filed October 9, 2012For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K on October 9, 2012, to report preliminary sales results for the third quarter of 2012. The primary purpose of this filing was to provide investors with an early look at the company's performance, driven by a press release issued on October 8, 2012. This proactive disclosure allows stakeholders to gauge the company's operational momentum and financial health prior to the official earnings release. While the 8-K itself does not contain the detailed financial figures, it references a press release (Exhibit 99.1) which is the source of the preliminary sales data. Investors should review this referenced press release for specific sales numbers and any commentary from management regarding the quarter's performance, particularly in key product segments like transcatheter heart valves and critical care technologies, as these are often drivers of growth for Edwards Lifesciences.

Key Highlights

  • 1Edwards Lifesciences (EW) filed an 8-K on October 9, 2012, to report preliminary Q3 2012 sales.
  • 2The filing incorporates by reference a press release dated October 8, 2012, containing the sales data.
  • 3This filing serves as an early disclosure of key financial performance indicators for the third quarter.
  • 4The information is provided to shareholders ahead of the full earnings report.
  • 5The report focuses on preliminary sales results and financial condition.
  • 6The Chief Financial Officer, Thomas M. Abate, signed the report.
  • 7The press release (Exhibit 99.1) is the primary source of the Q3 preliminary sales information.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce Edwards Lifesciences' preliminary sales results for the third quarter of 2012. This is done through the incorporation of a press release issued on October 8, 2012.

The actual preliminary sales numbers are detailed in the press release dated October 8, 2012, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this press release for specific figures.

This 8-K filing itself primarily serves as a notification of the preliminary sales data. Any commentary from management regarding the Q3 results would be found within the referenced press release (Exhibit 99.1).

No, the information furnished under Item 2.02 of this 8-K, including the press release, is specifically stated as not being deemed 'filed' for purposes of the Securities Exchange Act of 1934, as amended. This means it doesn't carry the same legal implications as information that is formally filed.